A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
BeOne Medicines
BeOne Medicines
Antengene Corporation
Novartis
Leap Therapeutics, Inc.
BeiGene
Hutchmed
Novartis
BeiGene
Novartis
Ohio State University Comprehensive Cancer Center
BeiGene
BeiGene
Henan Cancer Hospital
Fudan University
Celgene